解开瘤病:对独特的细胞死亡途径的形态和分子见解
Jie Guo1,2, Wen-Tao Yang3, Feng-Yi Mai4
1Department of Rehabilitation Medicine, Shenzhen Second People's Hospital, Shenzhen, China.
Frontiers in immunology
|September 16, 2024
概括
瘤病,一个被编程的细胞死亡途径,提供了一种新的治疗策略来对抗癌症耐药性和各种疾病. 这篇评论探讨了cosis.
科学领域:
- 细胞生物学 细胞生物学
- 分子医学是分子医学.
- 在瘤学瘤学.
背景情况:
- 编程细胞死亡 (PCD) 对健康和疾病至关重要.
- 癌细胞避开了亡,导致抗化学疗法.
- 瘤症作为一种具有治疗潜力的替代PCD途径而出现.
研究的目的:
- 审查瘤病的形态和分子特征.
- 讨论诱导瘤病的化合物.
- 探索瘤病在疾病中的作用和作为治疗点.
主要方法:
- 对瘤病研究的文献综述.
- 对瘤病的形态和分子特征的分析.
- 对天然和小分子诱导瘤病的检查.
主要成果:
- 瘤症的特征是细胞胀和器官细胞变化.
- 与瘤相关的蛋白质调解各种病理状况.
- 自然和小分子可以诱导瘤病.
结论:
- 瘤病症为疾病和癌症耐药性提供了一个有前途的治疗途径.
- 对瘤病变机制的进一步研究可以指导创新的治疗策略.
- 向瘤病可以克服癌症中的化疗耐药性.
更多相关视频
09:08Integration of Bioinformatics Approaches and Experimental Validations to Understand the Role of Notch Signaling in Ovarian Cancer
Published on: January 12, 2020
6.7K
09:18Identification of Intracellular Signaling Events Induced in Viable Cells by Interaction with Neighboring Cells Undergoing Apoptotic Cell Death
Published on: December 27, 2016
8.6K
相关概念视频
Overview of Cell Death
7.1K
Cell death is an essential process where the body gets rid of old or damaged cells. Cell proliferation and death need to be balanced, as an imbalance between the two may lead to cancer or autoimmune diseases.
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the...
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the...
7.1K
The Intrinsic Apoptotic Pathway
6.4K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.4K
The Extrinsic Apoptotic Pathway
6.3K
The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
6.3K
Apoptosis
11.3K
Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size...
11.3K
Autophagic Cell Death
3.4K
Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
3.4K
PI3K/mTOR/AKT Signaling Pathway
3.4K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.4K
